Oxidative stress and heart failure

American Journal of Physiology - Heart and Circulatory Physiology - Tập 301 Số 6 - Trang H2181-H2190 - 2011
Hiroyuki Tsutsui1, Shintaro Kinugawa1, Shouji Matsushima1
1Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Tóm tắt

Oxidative stress, defined as an excess production of reactive oxygen species (ROS) relative to antioxidant defense, has been shown to play an important role in the pathophysiology of cardiac remodeling and heart failure (HF). It induces subtle changes in intracellular pathways, redox signaling, at lower levels, but causes cellular dysfunction and damage at higher levels. ROS are derived from several intracellular sources, including mitochondria, NAD(P)H oxidase, xanthine oxidase, and uncoupled nitric oxide synthase. The production of ROS is increased within the mitochondria from failing hearts, whereas normal antioxidant enzyme activities are preserved. Chronic increases in ROS production in the mitochondria lead to a catastrophic cycle of mitochondrial DNA (mtDNA) damage as well as functional decline, further ROS generation, and cellular injury. ROS directly impair contractile function by modifying proteins central to excitation-contraction coupling. Moreover, ROS activate a broad variety of hypertrophy signaling kinases and transcription factors and mediate apoptosis. They also stimulate cardiac fibroblast proliferation and activate the matrix metalloproteinases, leading to the extracellular matrix remodeling. These cellular events are involved in the development and progression of maladaptive myocardial remodeling and failure. Oxidative stress is also involved in the skeletal muscle dysfunction, which may be associated with exercise intolerance and insulin resistance in HF. Therefore, oxidative stress is involved in the pathophysiology of HF in the heart as well as in the skeletal muscle. A better understanding of these mechanisms may enable the development of novel and effective therapeutic strategies against HF.

Từ khóa


Tài liệu tham khảo

10.1152/ajpheart.2002.282.1.H138

10.1161/CIRCRESAHA.109.213116

10.1161/01.CIR.0000142047.28024.F2

10.1146/annurev.cb.04.110188.001445

10.1161/01.RES.86.9.960

10.1161/01.CIR.100.3.292

10.1001/jama.287.19.2570

10.1136/hrt.65.5.245

10.1056/NEJMra0800239

10.1161/hc4501.098928

10.1161/hh1501.094115

10.1016/j.cardfail.2006.05.005

10.1146/annurev.cb.07.110191.002321

10.1056/NEJMoa010713

10.1056/NEJM198706043162301

10.1161/hh1501.094396

10.1016/0735-1097(96)00140-4

Dickstein K, 2008, Eur J Heart Fail, 10, 933, 10.1016/j.ejheart.2008.08.005

10.1161/01.CIR.0000017502.58595.ED

10.1161/01.RES.0000261657.76299.ff

10.1161/CIRCRESAHA.107.162800

10.1016/S0955-0674(03)00002-4

10.1038/labinvest.3780057

10.1007/s10741-010-9181-7

10.1016/S0167-5273(96)02787-8

10.1006/abbi.1995.1122

10.1056/NEJM199807233390404

10.1016/j.ijcard.2010.05.002

10.1016/j.ahj.2010.08.036

10.1253/circj.CJ-10-0599

10.1253/circj.CJ-09-0062

10.1152/ajpheart.00207.2003

10.1016/S0735-1097(03)00471-6

Hill MF, 1996, Am J Pathol, 148, 291

10.1161/01.CIR.96.7.2414

Hunt SA, 2009, Circulation, 119, e391

10.1161/01.RES.88.5.529

10.1161/01.RES.86.2.152

10.1161/01.RES.85.4.357

10.1161/CIRCULATIONAHA.104.524835

10.1001/jama.294.3.334

10.1093/gerona/glp100

10.1007/BF01322333

10.1152/ajpendo.00255.2001

10.1196/annals.1338.010

10.1001/jama.1979.03290450033020

10.1161/01.CIR.0000153349.77489.CF

10.1093/ajcn/73.2.219

10.1113/jphysiol.2003.042648

10.1161/01.RES.0000155331.09458.A7

10.1161/01.RES.87.5.392

10.1073/pnas.1002178107

10.1016/S0022-2828(03)00084-1

10.1038/nri1312

10.1172/JCI200314172

10.1097/01.hco.0000179821.11071.79

10.1006/jmcc.1993.1062

10.1074/jbc.M209793200

10.1161/hc4501.098944

10.1016/j.cardiores.2006.01.021

10.1001/jama.293.11.1338

10.1161/01.CIR.97.16.1536

10.2459/01.JCM.0000223257.09062.17

10.1161/CIRCULATIONAHA.105.582239

10.1152/ajpheart.00427.2006

10.1152/ajpheart.01332.2008

10.1056/NEJMcp0909392

10.1161/01.RES.0000200181.59551.71

10.1161/01.CIR.101.8.899

10.1161/01.CIR.0000139339.85840.DD

10.1016/j.cardiores.2003.11.027

10.1161/01.CIR.93.10.1905

10.1152/ajpheart.01185.2009

10.1152/physrev.00029.2006

10.1056/NEJM200105313442201

10.1016/S0002-9149(99)00097-1

10.4330/wjc.v3.i6.186

10.1152/ajpheart.1991.260.5.H1406

10.1016/S0140-6736(03)14282-1

10.1016/S0140-6736(00)02213-3

10.1056/NEJM199909023411001

10.1172/JCI119076

10.1016/j.jacc.2010.07.033

10.1161/01.CIR.99.23.3063

10.1016/j.cardiores.2005.01.021

10.1089/152308603770380034

10.1097/MAJ.0b013e3182249fcd

10.1161/01.RES.86.2.119

10.1161/hc3601.094298

10.1126/science.1106653

10.1161/01.RES.0000179580.72375.c2

10.1146/annurev.biochem.66.1.409

10.1016/S0735-1097(03)00509-6

10.1161/01.CIR.0000109701.77059.E9

10.1016/j.yjmcc.2005.07.004

10.1152/ajpheart.00026.2004

10.1161/01.RES.82.4.482

10.1161/01.CIR.0000055318.09997.1F

10.1172/JCI21968

10.1161/01.HYP.0000254415.31362.a7

10.1016/j.jacc.2007.02.053

10.1038/hr.2010.201

10.1038/hr.2009.199

10.1253/circj.CJ-09-0254

10.1253/circj.CJ-09-0993

10.1097/00005344-200106000-00010

10.1016/S0008-6363(00)00197-8

10.1161/hc4901.101347

10.1253/circj.71.449

10.1253/circj.70.1617

10.1161/01.CIR.103.5.750

10.1152/physiolgenomics.00122.2003

Williams RS, 1986, J Biol Chem, 261, 12390, 10.1016/S0021-9258(18)67252-7

10.1016/j.jacc.2004.03.037

10.1152/ajpcell.00045.2009

10.1111/j.1742-4658.2007.05914.x

10.1016/j.cardiores.2006.02.019